Advertisement

Topics

Oncology Sponsors Getting A Jump On Pediatric Study Requirements, US FDA Says

18:25 EDT 25 Mar 2019 | SCRIP

Beginning in August 2020, applications for some novel cancer drugs and biologics will have to include reports on molecularly targeted...

      

Related Stories

 

Original Article: Oncology Sponsors Getting A Jump On Pediatric Study Requirements, US FDA Says

NEXT ARTICLE

More From BioPortfolio on "Oncology Sponsors Getting A Jump On Pediatric Study Requirements, US FDA Says"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...